Tilray
Tilray is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in 13 countries spanning five continents. Tilray supports clinical and observational studies in Canada, the United States, the European Union, and Australia, examining the efficacy of medical cannabis as a treatment for pediatric epilepsy, essential tremor, post-traumatic stress disorder, and alcohol use disorder, and to address the side effects of cancer chemotherapy.Content by Tilray
Filter by
AllArticlesAudioEbooksEventsInfographicsNewsProductsSurveysDocumentsVideosVirtual EventsWebinars
The deliberate use of medical cannabis to reduce alcohol consumption was linked to a greater likelihood of reducing and ceasing alcohol use after starting medical cannabis
| 2 min read
Page 1 of 1 - 1 Total Items
